Michael D. West
| Michael D. West, PhD | |
|---|---|
 |
|
| Born | Niles, Michigan, USA |
| Residence | Northern California |
| Citizenship | United States |
| Alma mater |
Rensselaer Polytechnic Institute (B.S.) Andrews University (M.S.) Baylor College of Medicine (Ph.D.) |
| Known for | CEO of BioTime, Founder of Geron Corporation, former CEO of Advanced Cell Technology, research in gerontology, stem cell science, cellular aging, and telomeres |
| Influences | James Thomson, Elizabeth Blackburn, Leonard Hayflick |
Michael D. West, PhD, is a gerontologist, and a pioneer in stem cells,cellular aging and telomere researcher, previous CEO of Advanced Cell Technology aka Ocata (NASDAQ: OCAT), founder of Geron (NASDAQ: GERN) (a J&J partner) and is the current CEO of BioTime, Inc. (NYSE MKT: BTX) of Alameda, California (San Francisco Bay Area), a biotechnology company regarded as a leader in the field of regenerative medicine with a focus on Cell Therapies based on pluripotent stem cells that are regarded as all powerful with the ability to become all cells types of the human body. BioTime stock is traded on the NYSE MKT and TASE change under ticker symbol BTX.
Prior to joining BioTime, West was Chairman of the Board, Chief Scientific Officer and CEO of Advanced Cell Technology, Inc. who changed its name to Ocata Therapeutics (OCAT) that also specializes in stem cell research and was acquired by Japanese big pharmaceutical company, Astellas for US$379M or $8.50 per share in February 2016. Prior that, he was founder, director, and Chief Scientific officer of Geron, for which he secured venture capital investment from Kleiner Perkins Caufield & Byers, Venrock and Domain Associates. At Geron, West initiated and managed programs in telomere biology relating to aging, cancer and human embryonic stem cell technology.
...
Wikipedia